Methods for producing aflibercept in chemically defined media having reduced aflibercept variants | Patent Publication Number 20210206832

US 20210206832 A1
Patent NumberUS 11104715 B2
Application Number16996030
Filled DateAug 18, 2020
Priority DateDec 6, 2019
Publication DateJul 8, 2021
Original AssigneeRegeneron Pharmaceuticals
Current AssigneeRegeneron Pharmaceuticals
Inventor/ApplicantsAmy Johnson
Shunhai Wang
Shawn Lawrence
Ning Li
Jaimie Mastrogiacomo
Meghan Casey
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.